| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700098 | 重组抗TNFα全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-11-01 | 安徽未名达木生物医药有限公司 | Anhui Weiming Damu Biomedical Co Ltd | Certificate Issued | 2018-09-03 | view |